Converge Technology Solutions Corp. (CTS.TO)
CAD 3.27
(-4.39%)
CAD 3.27
(-4.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 195.81 Million | 41.58 Million | 87.06 Million | 51.6 Million | 26.81 Million | 1.06 Million |
| Net Income | -1.44 Million | 22.84 Million | 16.36 Million | -4.17 Million | -10.84 Million | -18.23 Million |
| Depreciation & Amortization | 119.98 Million | 80.06 Million | 39.58 Million | 27.04 Million | 17.88 Million | 6.95 Million |
| Deferred income taxes | -33.89 Million | -4.05 Million | 7.6 Million | 1.67 Million | -1.91 Million | 2.64 Million |
| Stock-based compensation | 3.69 Million | 5.59 Million | 2.32 Million | - | - | - |
| Change in working capital | 90.74 Million | -77.17 Million | 7.63 Million | 6.25 Million | 4.35 Million | -4.6 Million |
| Other non-cash items | 165.55 Million | 14.31 Million | 13.54 Million | 20.79 Million | 17.32 Million | 14.99 Million |
| Investing Cash Flow | -103.92 Million | -463.42 Million | -277.8 Million | -66.59 Million | -66.76 Million | -33.66 Million |
| Investments in PPE | -10.82 Million | -23.94 Million | -6.31 Million | -4.99 Million | -1.8 Million | -2.27 Million |
| Acquisitions | -93.09 Million | -418.14 Million | -260.55 Million | -43.79 Million | -55.19 Million | -26.2 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -96.85 Million | -21.33 Million | -10.94 Million | -17.8 Million | -9.77 Million | -5.17 Million |
| Financing Cash Flow | -84.8 Million | 336.31 Million | 371.38 Million | 58.53 Million | 52.41 Million | 35.6 Million |
| Debt repayment | -40.63 Million | -12.52 Million | -149.95 Million | -1.16 Billion | -829.8 Million | -224.52 Million |
| Dividends payments | -6.15 Million | -1.08 Million | - | - | - | - |
| Common Stock Repurchased | -17.38 Million | -40 Million | - | -2.12 Million | - | - |
| Common Stock Issuance | - | - | 493.88 Million | 103.59 Million | 2.34 Million | 12.22 Million |
| Other Financing Activities | 4.68 Million | 389.92 Million | 27.45 Million | 2.24 Billion | 879.87 Million | 247.89 Million |
| Accounts receivables | -98.24 Million | -125.83 Million | 33 Million | -114 Million | -32.76 Million | -87.01 Million |
| Accounts payables | 111.32 Million | 33.17 Million | 25.8 Million | 123.61 Million | 45.41 Million | 80.78 Million |
| Inventory | 81.75 Million | 38.14 Million | -56.54 Million | -10.89 Million | -7.73 Million | -1.22 Million |
| Other working capital | -4.09 Million | -22.65 Million | 5.37 Million | 7.52 Million | -563 Thousand | 2.85 Million |
| Cash at beginning of period | 165.12 Million | 248.19 Million | 64.76 Million | 20.59 Million | 10.48 Million | 7.78 Million |
| Cash at end of period | 170.41 Million | 159.89 Million | 248.19 Million | 64.76 Million | 20.59 Million | 10.48 Million |
| Capital Expenditure | -10.82 Million | -23.94 Million | -6.31 Million | -4.99 Million | -1.8 Million | -2.27 Million |
| Effect of forex changes on cash | -1.78 Million | -2.77 Million | 2.77 Million | 628 Thousand | -2.34 Million | -313 Thousand |
| Net cash flow / Change in cash | 5.29 Million | -88.3 Million | 183.42 Million | 44.17 Million | 10.1 Million | 2.69 Million |
| Free Cash Flow | 184.98 Million | 17.64 Million | 80.75 Million | 46.61 Million | 25 Million | -1.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -163.31 Million | -1.91 Million | 5.86 Million | -1.44 Million | -3.31 Million | -4.49 Million |
| Depreciation & Amortization | 26.97 Million | 27.04 Million | 31.63 Million | 119.98 Million | 31.55 Million | 29.23 Million |
| Deferred income taxes | -7.65 Million | 3.56 Million | -33.89 Million | -33.89 Million | -1.05 Million | -1.95 Million |
| Stock-based compensation | 1.14 Million | 772 Thousand | 954 Thousand | 3.69 Million | 774 Thousand | 1.11 Million |
| Change in working capital | 36.23 Million | 73.12 Million | 71.88 Million | 90.74 Million | 63.1 Million | -40.34 Million |
| Other non-cash items | 171.79 Million | -10.86 Million | 31.23 Million | 165.55 Million | 4.88 Million | 6.8 Million |
| Investing Cash Flow | -22.16 Million | -12.88 Million | -3.26 Million | -103.92 Million | -27.56 Million | -3.45 Million |
| Investments in PPE | -2 Million | -1.85 Million | -2.03 Million | -10.82 Million | -1.59 Million | -2.09 Million |
| Acquisitions | -20.16 Million | -11.02 Million | -1.23 Million | -93.09 Million | -25.96 Million | -1.36 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -20.16 Million | -7.86 Million | -1.23 Million | -96.85 Million | -25.96 Million | -5.04 Million |
| Financing Cash Flow | -9.74 Million | -105.72 Million | -39.48 Million | -84.8 Million | -41.16 Million | -49.23 Million |
| Debt repayment | -41.79 Million | -96.31 Million | -29.92 Million | -40.63 Million | -26.99 Million | -27.94 Million |
| Dividends payments | -2.96 Million | -2.03 Million | -2.04 Million | -6.15 Million | -2.04 Million | -2.06 Million |
| Common Stock Repurchased | -44.42 Million | -2.29 Million | -2.09 Million | -17.38 Million | -1.06 Million | -14.23 Million |
| Common Stock Issuance | 875 Thousand | - | - | - | -10.54 Million | -7.36 Million |
| Other Financing Activities | 1.17 Million | -3000.00 | 2.61 Million | 4.68 Million | -519 Thousand | 2.37 Million |
| Accounts receivables | -126 Million | 13.88 Million | -61.84 Million | -98.24 Million | -13.36 Million | -20.59 Million |
| Accounts payables | 151.15 Million | 68.55 Million | 32.95 Million | 111.32 Million | 81.47 Million | -3.88 Million |
| Inventory | 3.94 Million | -11.57 Million | 91.97 Million | 81.75 Million | -4.1 Million | -7.44 Million |
| Other working capital | 7.13 Million | 2.26 Million | 8.79 Million | -4.09 Million | -902 Thousand | -8.42 Million |
| Cash at beginning of period | 158.61 Million | 170.41 Million | 108.32 Million | 165.12 Million | 78.44 Million | 139.02 Million |
| Cash at end of period | 174.08 Million | 158.61 Million | 170.41 Million | 170.41 Million | 105.22 Million | 78.44 Million |
| Capital Expenditure | -2 Million | -1.85 Million | -2.03 Million | -10.82 Million | -1.59 Million | -2.09 Million |
| Effect of forex changes on cash | 1.63 Million | 2.64 Million | -1.75 Million | -1.78 Million | -439 Thousand | 1.74 Million |
| Net cash flow / Change in cash | 15.47 Million | -11.8 Million | 62.09 Million | 5.29 Million | 26.77 Million | -60.58 Million |
| Free Cash Flow | 44.82 Million | 102.3 Million | 104.5 Million | 184.98 Million | 94.34 Million | -11.73 Million |
9936
S
CKSNF
BIOGF
1023
RGXTF